KEGG: dre:553700
UniGene: Dr.79847
CREB3L3, also known as cyclic AMP-responsive element-binding protein 3-like protein 3, is a transcription factor primarily localized to the endoplasmic reticulum (ER). It plays a pivotal role in cellular stress management by activating genes involved in the unfolded protein response (UPR) and acute phase response during ER stress . CREB3L3 contains domains such as a leucine zipper and a basic leucine zipper (bZIP) that facilitate DNA binding and dimerization . Its functions extend to regulating hepatic metabolism, triglyceride levels, and inflammatory responses . Importantly, CREB3L3 has been implicated as a tumor suppressor in hepatocellular carcinoma (HCC), where its underexpression correlates with disease progression .
CREB3L3 antibodies are employed in various experimental applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHC-P), and enzyme-linked immunosorbent assay (ELISA) . These methods allow researchers to detect CREB3L3 protein in specific tissues or cell lines, quantify its expression levels, and study its interactions with other molecules. For instance, immunoprecipitation can be used to identify proteins that interact with CREB3L3, while WB provides quantitative data on its expression across different conditions .
To ensure the reliability of results, researchers must include appropriate controls when using CREB3L3 antibody. Negative controls, such as samples lacking the target protein or using isotype-matched non-specific antibodies, help confirm specificity. Positive controls, including samples known to express CREB3L3 at high levels (e.g., liver tissue under ER stress conditions), validate the antibody's efficacy . Additionally, loading controls like actin or tubulin are essential for normalization in WB experiments .
CREB3L3 plays a critical role in maintaining normal plasma triglyceride concentrations by regulating the transcription of fibroblast growth factor 21 (FGF21) . FGF21 is a hormone that influences lipid metabolism and energy homeostasis. CREB3L3's activation during ER stress or cAMP stimulation leads to increased FGF21 expression, which subsequently modulates triglyceride levels . This regulatory pathway underscores CREB3L3's importance in metabolic health.
CREB3L3 contains several key structural domains that facilitate its function as a transcription factor. These include a leucine zipper domain for dimerization and a basic leucine zipper (bZIP) domain for DNA binding . Additionally, its KDEL-like sequence ensures retention within the ER until activation. Upon activation by ER stress or cAMP signaling, CREB3L3 undergoes proteolytic cleavage and translocates to the nucleus to initiate transcription .
CREB3L3 acts as a tumor suppressor in hepatocellular carcinoma (HCC) by inhibiting AKT signaling pathways . Mechanistically, it competes with insulin receptor substrate 1 (IRS1) for binding to the insulin receptor (INSR), thereby reducing AKT phosphorylation and activity . This suppression of AKT signaling curtails cell proliferation and metastasis while promoting apoptosis in HCC cells . Furthermore, high expression levels of CREB3 are associated with better prognosis in HCC patients .
Researchers may encounter several challenges when interpreting data from CREB3L3 antibody experiments:
Cross-reactivity: Some antibodies may bind non-specifically to other proteins sharing homologous sequences.
Isoform specificity: CREB3L3 exists in multiple isoforms due to alternative splicing; antibodies may preferentially detect certain isoforms.
Experimental variability: Differences in sample preparation, antibody dilution, and detection methods can lead to inconsistent results.
Biological context: The functional state of CREB3L3 (e.g., active vs inactive) may influence its detectability .
Careful experimental design and validation are essential to mitigate these issues.
Protein-protein interactions involving CREB3L3 can be studied using co-immunoprecipitation (co-IP) assays followed by mass spectrometry or western blotting . For example, co-IP experiments have revealed that CREB3 interacts with INSR to regulate AKT signaling in HCC cells . Additionally, proximity ligation assays (PLA) can be employed for visualizing interactions at subcellular levels.
ER stress triggers the activation of CREB3L3 through proteolytic cleavage mechanisms . Under stress conditions such as accumulation of misfolded proteins or lipid imbalances, CREB family members respond by initiating UPR pathways. For CREB3L3 specifically, this involves translocation from the ER to the nucleus where it binds DNA elements like cAMP response element (CRE) to activate target genes involved in stress mitigation .
The specificity of a new anti-CREB antibody can be validated through several approaches:
Western blotting: Demonstrate exclusive detection of bands corresponding to expected molecular weights.
Immunoprecipitation: Confirm enrichment of target protein from cell lysates.
Knockdown/Knockout studies: Use RNA interference or CRISPR/Cas9 technology to eliminate target expression; absence of signal validates specificity.
Immunofluorescence: Show colocalization with known subcellular markers for the target protein.
Mass spectrometry: Identify peptides corresponding uniquely to the target protein following IP experiments .